382 related articles for article (PubMed ID: 16272055)
21. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
Nagy D; Schönfisch B; Zrenner E; Jägle H
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
[TBL] [Abstract][Full Text] [Related]
22. Four novel RS1 gene mutations in Polish patients with X-linked juvenile retinoschisis.
Skorczyk A; Krawczyński MR
Mol Vis; 2012; 18():3004-12. PubMed ID: 23288992
[TBL] [Abstract][Full Text] [Related]
23. Two cases of X-linked juvenile retinoschisis with different optical coherence tomography findings and RS1 gene mutations.
Chan WM; Choy KW; Wang J; Lam DS; Yip WW; Fu W; Pang CP
Clin Exp Ophthalmol; 2004 Aug; 32(4):429-32. PubMed ID: 15281981
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic variation in enhanced S-cone syndrome.
Audo I; Michaelides M; Robson AG; Hawlina M; Vaclavik V; Sandbach JM; Neveu MM; Hogg CR; Hunt DM; Moore AT; Bird AC; Webster AR; Holder GE
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2082-93. PubMed ID: 18436841
[TBL] [Abstract][Full Text] [Related]
25. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options.
Boon CJ; van den Born LI; Visser L; Keunen JE; Bergen AA; Booij JC; Riemslag FC; Florijn RJ; van Schooneveld MJ
Ophthalmology; 2013 Apr; 120(4):809-20. PubMed ID: 23290749
[TBL] [Abstract][Full Text] [Related]
26. Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis.
Min SH; Molday LL; Seeliger MW; Dinculescu A; Timmers AM; Janssen A; Tonagel F; Tanimoto N; Weber BH; Molday RS; Hauswirth WW
Mol Ther; 2005 Oct; 12(4):644-51. PubMed ID: 16027044
[TBL] [Abstract][Full Text] [Related]
27. X-linked retinoschisis: RS1 mutation severity and age affect the ERG phenotype in a cohort of 68 affected male subjects.
Bowles K; Cukras C; Turriff A; Sergeev Y; Vitale S; Bush RA; Sieving PA
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9250-6. PubMed ID: 22039241
[TBL] [Abstract][Full Text] [Related]
28. Retinoschisin gene therapy and natural history in the Rs1h-KO mouse: long-term rescue from retinal degeneration.
Kjellstrom S; Bush RA; Zeng Y; Takada Y; Sieving PA
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3837-45. PubMed ID: 17652759
[TBL] [Abstract][Full Text] [Related]
29. Genotypic and phenotypic diversity in X-linked retinoschisis: Findings from a South Indian patient cohort.
Chowdhury S; Chermakani P; Baliga G; Anjanamurthy R; Sundaresan P
Indian J Ophthalmol; 2024 Jun; 72(6):902-911. PubMed ID: 38317323
[TBL] [Abstract][Full Text] [Related]
30. Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.
Wissinger B; Dangel S; Jägle H; Hansen L; Baumann B; Rudolph G; Wolf C; Bonin M; Koeppen K; Ladewig T; Kohl S; Zrenner E; Rosenberg T
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):751-7. PubMed ID: 18235024
[TBL] [Abstract][Full Text] [Related]
31. X-linked retinoschisis: novel mutation in the initiation codon of the XLRS1 gene in a large family.
Kim DY; Neely KA; Sassani JW; Vrabec TR; Tantri A; Frost A; Donoso LA
Retina; 2006 Oct; 26(8):940-6. PubMed ID: 17031297
[TBL] [Abstract][Full Text] [Related]
32. Pseudoxanthoma elasticum with generalized retinal dysfunction, a common finding?
Audo I; Vanakker OM; Smith A; Leroy BP; Robson AG; Jenkins SA; Coucke PJ; Bird AC; De Paepe A; Holder GE; Webster AR
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4250-6. PubMed ID: 17724214
[TBL] [Abstract][Full Text] [Related]
33. An ENU-induced mutation in Rs1h causes disruption of retinal structure and function.
Jablonski MM; Dalke C; Wang X; Lu L; Manly KF; Pretsch W; Favor J; Pardue MT; Rinchik EM; Williams RW; Goldowitz D; Graw J
Mol Vis; 2005 Jul; 11():569-81. PubMed ID: 16088326
[TBL] [Abstract][Full Text] [Related]
34. Genotypic and phenotypic spectrum of X-linked retinoschisis in Australia.
Hewitt AW; FitzGerald LM; Scotter LW; Mulhall LE; McKay JD; Mackey DA
Clin Exp Ophthalmol; 2005 Jun; 33(3):233-9. PubMed ID: 15932525
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of macular structure and function by OCT and electrophysiology in patients with vitelliform macular dystrophy due to mutations in BEST1.
Schatz P; Bitner H; Sander B; Holfort S; Andreasson S; Larsen M; Sharon D
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4754-65. PubMed ID: 20375334
[TBL] [Abstract][Full Text] [Related]
36. Coexpression and interaction of wild-type and missense RS1 mutants associated with X-linked retinoschisis: its relevance to gene therapy.
Dyka FM; Molday RS
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2491-7. PubMed ID: 17525175
[TBL] [Abstract][Full Text] [Related]
37. Late onset is common in best macular dystrophy associated with VMD2 gene mutations.
Renner AB; Tillack H; Kraus H; Krämer F; Mohr N; Weber BH; Foerster MH; Kellner U
Ophthalmology; 2005 Apr; 112(4):586-92. PubMed ID: 15808248
[TBL] [Abstract][Full Text] [Related]
38. Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling.
Vijayasarathy C; Sardar Pasha SPB; Sieving PA
Prog Retin Eye Res; 2022 Mar; 87():100999. PubMed ID: 34390869
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic Characteristics of a French Cohort of Patients with X-Linked Retinoschisis.
Orès R; Mohand-Said S; Dhaenens CM; Antonio A; Zeitz C; Augstburger E; Andrieu C; Sahel JA; Audo I
Ophthalmology; 2018 Oct; 125(10):1587-1596. PubMed ID: 29739629
[TBL] [Abstract][Full Text] [Related]
40. Fundus autofluorescence in carriers of choroideremia and correlation with electrophysiologic and psychophysical data.
Preising MN; Wegscheider E; Friedburg C; Poloschek CM; Wabbels BK; Lorenz B
Ophthalmology; 2009 Jun; 116(6):1201-9.e1-2. PubMed ID: 19376587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
